Excessive cardiorespiratory responses to CO are a hallmark of panic disorder (PD). Female sex and exposure to early life stress are risk factors for PD. Neonatal maternal separation (NMS; 3 h/day, postnatal days 3-12) augments the ventilatory response to CO by ∼35% relative to controls; this effect is most notable during pro-oestrus but is not observed in males. Orexin-1 receptor (OX1-R) antagonism attenuates the CO response of NMS females. In the limbic system, stress and ovarian hormones influence OX1-R expression, but the impact of these factors on OX1-Rs in regions regulating the cardiorespiratory responses to CO is unknown. Here, we hypothesised that ovarian hormones and NMS determine OX1-R expression in structures regulating the CO response; we used in situ hybridisation to quantify OX-1R mRNA expression in the brains of adult NMS and control rats. Brains were harvested from females that were either in pro-oestrus (high ovarian hormones) or 2 weeks post ovariectomy (OVX; low ovarian hormones); males were included for comparison. Hormonal status influenced the intensity of the OX1-R signal in the medial amygdala, raphe obscurus (RObs) and the A5 area, but the direction of the changes (increase vs. decrease) was structure-specific. Significant NMS × hormonal status interactions were noted in the dorsal raphe, the locus coeruleus, the nucleus of the solitary tract and the A5 area; the effects were structure-specific. As the dorsal raphe was the only structure in which the changes in OX1-R expression matched the sex-specific effect of NMS on the CO response, this structure likely contributes to respiratory manifestations of PD.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1113/EP092431 | DOI Listing |
Sci Rep
March 2025
School of Life sciences, Jining Medical University, Rizhao City, Shandong, China.
Cyclophosphamide (CTX) exposure causes premature ovarian insufficiency (POI). The therapeutic potential of exosomes derived from human umbilical cord mesenchymal stem cells (hucMSCs) is not fully understood, especially regarding whether hypoxic preconditioning enhances their efficacy in POI. In this study, exosomes were isolated and identified from hucMSCs (hucMSCs-Exos) under hypoxic (HExos) and normoxic (NExos) conditions.
View Article and Find Full Text PDFReproduction
March 2025
V Hellier, PRC, INRAE Centre Val de Loire, Nouzilly, France.
Hyperprolactinaemia (HPRL), characterized by elevated prolactin levels, disrupts the hypothalamic-pituitary-gonadal axis, leading to reproductive dysfunctions such as menstrual irregularities, anovulation, and infertility. Current treatments rely on dopamine agonists but are limited by side effects and resistance. Kisspeptin (Kp), a key neuropeptide regulating the reproductive function, offers potential as an alternative therapy.
View Article and Find Full Text PDFTurk J Obstet Gynecol
March 2025
Acıbadem University Faculty of Medicine, Department of Obstetrics and Gynecology, İstanbul, Türkiye.
Objective: Controlled ovarian hyperstimulation plays a critical role in in vitro fertilization (IVF) success. However, premature luteinization and variations in oocyte yield can impact IVF outcomes. This comparative study aims to investigate the effects of gonadotropin releasing hormone antagonist (GNRHant) and oral progestin-primed protocol on the oocyte count over the punctured follicle number in the same patient group undergoing consecutive IVF cycles.
View Article and Find Full Text PDFCureus
February 2025
Department of Biomedical Education, California Health Sciences University College of Osteopathic Medicine, Clovis, USA.
Glucagon-like peptide 1 (GLP-1), an incretin hormone primarily secreted by L-cells in the gut, prompts insulin release, thus reducing blood sugar levels and causing weight loss by inducing feelings of fullness while curbing appetite. GLP-1 receptor agonists (GLP-1 RAs) mimic its effects, proving highly effective in managing type 2 diabetes mellitus (T2DM) and facilitating weight loss. While predominantly approved for T2DM and obesity, GLP-1 RAs also hold promise for treating other conditions like heart and kidney disease, with ongoing research exploring additional therapeutic applications.
View Article and Find Full Text PDFGynecol Oncol Rep
April 2025
Department of Gynecologic Oncology, Willamette Valley Cancer Institute and Research Center 520 Country Club, Eugene, OR 97401, United States.
Low-grade serous ovarian carcinoma (LGSOC) is a rare malignancy in pediatric populations, with most ovarian tumors in adolescents typically being of germ cell origin. LGSOC is a distinct subtype of serous ovarian carcinoma characterized by slow progression, frequent estrogen receptor (ER) positivity, and resistance to traditional chemotherapy. Despite its indolent nature, most patients ultimately experience disease recurrence, highlighting the need for alternative treatment approaches.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!